These have been reviewed by Masuda et al. [70], who provided evidence that the inhibitory effects of EGCG on HNSCC cells are associated with modulation of signal transduction pathways triggered by signaling through EGFR and other receptor tyrosine kinases. Here, EGFR is linked to head and neck squamous cell carcinoma.